Navigation Links
CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
Date:10/13/2008

CoreValve (www.corevalve.com) announced today that the expanded clinical evaluation of its ReValving System for percutaneous aortic valve replacement (PAVR) in high-risk patients with aortic stenosis continues to enroll patients at an accelerating pace. More than 1,800 patients have now been treated worldwide at nearly 100 centers in 20 countries.

IRVINE, Calif. (Business Wire EON) October 13, 2008 -- During the Monday Transcatheter Aortic Valve Replacement sessions at TCT 2008 meeting in Washington, D.C., CoreValve investigators and physician proctors presented clinical data on the subset of patients that are included in the company's post CE-Mark expanded clinical evaluation registry. Patients enrolled in the registry had a predicted 30-day mortality rate of about 23% as measured by the logistical EuroScore. By contrast, the survival rate at one-month post-procedure follow-up for these high-risk and often inoperable octogenarian registry patients was about 90%. Quality of life improvement, as measured by the New York Heart Association (NYHA) functional classification, was significantly improved as well. Follow-up on patients that are now one year post procedure demonstrate good longer term valve function and sustained survival and quality of life benefits. CoreValve believes that complications including neurological events are comparable to traditional aortic valve surgery although there is a modest, but clinically acceptable increase in pacemaker dependency in PAVR patients.

"The growing volume of very positive clinical data from an ever increasing number of physicians is most satisfying," said Eberhard Grube MD, Chief of Cardiology at the HELIOS Heart Center Siegburg, Germany. "In the hands of an experienced user, use of the CoreValve ReValving System is fast becoming a routine alternative for high risk patients suffering from severe aortic stenosis."

"We are highly encouraged by the clinical data from outside the United States that was presented at TCT," added Daniel T. Lemaitre, President and CEO of CoreValve. "Additionally, we continue to see strong sequential growth in procedure volume as 2008 unfolds; a testimony to the significant patient population whom we believe will benefit from our groundbreaking technology."

About CoreValve

CoreValve, Inc., is headquartered in Irvine, Calif. Its proprietary ReValving System allows both percutaneous aortic valve replacement (PAVR) and transapical aortic valve replacement (TAVR) and is intended to provide an alternative to open-heart surgery. The ReValving System procedures are performed on the beating heart without cardiac assistance or rapid pacing, and may result in less trauma to the patient. This technology may also offer substantial cost-savings to the healthcare system. The catheter-based technology includes a proprietary framed/self-expanding tissue heart valve that is specifically designed and engineered for transcatheter delivery. For more information about CoreValve, visit the Company's Web site at www.corevalve.com.

(Caution: the CoreValve ReValving System will not be available in the USA for clinical trials or for sale until further notice.)

Read the full story at http://www.prweb.com/releases/aortic_valve/valve_replacement/prweb1466554.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Edwards Lifesciences Initiates Patent Infringement Litigation Against CoreValve in the U.S.
2. RF Technologies(R) Announces Code Alert(R) Integrated Care Management Solution
3. CIO Healthcare Summit Announces Dates and VIP Delegates
4. Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region
5. HealthSouth Announces Plans to Build New Hospital in Arizona
6. Life Spine Announces Acquisition of Intellectual Property
7. Robbins & Myers Announces Regular Quarterly Cash Dividend
8. Boston Scientific Announces Third Quarter Adjustments
9. U.S. Department of Labor announces $1.2 million grant to provide nearly 700 North Carolina workers with health insurance payments as part of Trade Adjustment Assistance benefits
10. Vyta Corp Announces Engagement of Dr. Nino Sorgente as Independent Consultant
11. Disaboom Announces Preliminary Third Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) :  Highly encouraging registry data also presented at TCT 2008 
(Date:8/22/2017)... NASHVILLE, Tenn. (PRWEB) , ... August 22, 2017 ... ... Company, is pleased to announce the addition of Zack Tisch as the ... services for the KLAS-ranked healthcare IT consulting firm’s national accounts, from assisting clients ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: ... a B17 bomber named Edward Koontz. “To Walk Away” is the creation of published ... has published over two hundred manuscripts in chemistry and religion, as well as four ...
(Date:8/22/2017)... ... August 22, 2017 , ... John Stewart ... and Managing Member for t4 Leadership Development & Consulting. He has spent his ... of “success”: physician leadership development, servant leadership, data driven process improvement, and supportive ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... without risk to health and safety. By learning and implementing best practices for ... , In this webinar, attendees will gain a better understanding of a method ...
(Date:8/21/2017)... ... 2017 , ... Five chefs from local senior assisted living homes will serve ... Guests will be able to vote for their favorite Chef among the following: , ... Salad, Feta Cheese Sauce & Garlic Pita Crisp, Greek Mountain Ice Tea , ITALY, ...
Breaking Medicine News(10 mins):
(Date:8/10/2017)... LAKEWOOD, Colo. , Aug. 10, 2017  Physical Rehabilitation ... Therapy, located in Lakewood, Colorado . The ... Jeff Lipkin , PT, DPT with his staff of ... the University of Pittsburgh and brings over 10 years of ... Belmar PT marks the 10th PRN clinic ...
(Date:8/8/2017)...   Second-quarter 2017 ... loss per share from continuing operations ... 16 percent to $110 million ... to $161 million Second-quarter ... operations increased 8 percent to $0.93 ...
(Date:8/7/2017)... Ind. , Aug. 7, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that its Board of Directors has ... for the third quarter of 2017. ... be paid on or about October 27, 2017 to stockholders ... 22, 2017.  Future declarations of dividends are subject to approval ...
Breaking Medicine Technology: